mammaprint

MammaPrint® - Agendia’s Risk Of Recurrence Test

1:38

MammaPrint® - Agendia’s Risk Of Recurrence Test
Genomic testing in early breast cancer: MammaPrint & BluePrint

2:00

Genomic testing in early breast cancer: MammaPrint & BluePrint
Genomic Profiling in early stage breast cancer & Role of Mammaprint & Blueprint testing | Oncquest

29:58

Genomic Profiling in early stage breast cancer & Role of Mammaprint & Blueprint testing | Oncquest
Patient Experiences with MammaPrint®

3:56

Patient Experiences with MammaPrint®
Dr. Soliman on Impact of MammaPrint in Patients With Early-Stage Breast Cancer

1:28

Dr. Soliman on Impact of MammaPrint in Patients With Early-Stage Breast Cancer
Using MammaPrint to select patients who may not need adjuvant chemotherapy – the results of MINDACT

3:56

Using MammaPrint to select patients who may not need adjuvant chemotherapy – the results of MINDACT
Comparing MammaPrint to Oncotype Dx

13:43

Comparing MammaPrint to Oncotype Dx
MammaPrint genetic testing reduces chemotherapy overtreatment in breast cancer patients

9:14

MammaPrint genetic testing reduces chemotherapy overtreatment in breast cancer patients
Mammaprint Blueprint, Updates from MINDACT 8.7 Year, & Applications in Neoadjuvant Therapy

1:11:28

Mammaprint Blueprint, Updates from MINDACT 8.7 Year, & Applications in Neoadjuvant Therapy
Introduction and Walkthrough: Summary of Results for MammaPrint and BluePrint

13:41

Introduction and Walkthrough: Summary of Results for MammaPrint and BluePrint
The 70-gene signature (MammaPrint) accurately predicts distant breast cancer recurrence

2:21

The 70-gene signature (MammaPrint) accurately predicts distant breast cancer recurrence
How MammaPrint and BluePrint Reclassifies Tumors Based on Tumor Biology, Ian Grady, MD FACS

1:17

How MammaPrint and BluePrint Reclassifies Tumors Based on Tumor Biology, Ian Grady, MD FACS
Combining Pathology, MammaPrint and BluePrint

1:02:00

Combining Pathology, MammaPrint and BluePrint
How to place an order for MammaPrint and BluePrint using the online portal (EN)

6:35

How to place an order for MammaPrint and BluePrint using the online portal (EN)
MammaPrint® & BluePrint®

2:46

MammaPrint® & BluePrint®
MammaPrint

4:44

MammaPrint
MINDACT long-term results: 70-gene signature MammaPrint to guide adjuvant chemotherapy use in br...

9:35

MINDACT long-term results: 70-gene signature MammaPrint to guide adjuvant chemotherapy use in br...
Beth DuPree, MD FACS ABOHM Statement On Genomic Testing, MammaPrint & BluePrint

1:29

Beth DuPree, MD FACS ABOHM Statement On Genomic Testing, MammaPrint & BluePrint
Short Review: General Overview of Invasive Ductal Carcinoma (Breast)

23:17

Short Review: General Overview of Invasive Ductal Carcinoma (Breast)
Predicting Progression of DCIS to Invasive Cancer

31:53

Predicting Progression of DCIS to Invasive Cancer
The Use of Genomic MammaPrint BluePrint in Neoadjuvant Breast Cancer Dr James Pellicane

1:01:50

The Use of Genomic MammaPrint BluePrint in Neoadjuvant Breast Cancer Dr James Pellicane
TESTY GENETYCZNE- MammaPrint i BluePrint

00:44

TESTY GENETYCZNE- MammaPrint i BluePrint
MammaPrint- de duidelijkheid wanneer je die het hardst nodig hebt

1:22

MammaPrint- de duidelijkheid wanneer je die het hardst nodig hebt
Carmen's Story

1:05

Carmen's Story
The Role of BRCA1 in Cancer

8:25

The Role of BRCA1 in Cancer
Latonya's Story - Don't Lump Me In

00:38

Latonya's Story - Don't Lump Me In
Beth DuPree, MD FACS ABOHM Presents Case Study On 50yr Female With Invasive Ductal Carcinoma, Grade3

4:23

Beth DuPree, MD FACS ABOHM Presents Case Study On 50yr Female With Invasive Ductal Carcinoma, Grade3
MammaPrint Identifies Which Breast Cancer Patients Can Bypass Chemotherapy

1:58

MammaPrint Identifies Which Breast Cancer Patients Can Bypass Chemotherapy
Pronounce Medical Words ― MammaPrint

00:09

Pronounce Medical Words ― MammaPrint
Genomic Testing in Breast Cancer: What You Must Know

14:37

Genomic Testing in Breast Cancer: What You Must Know
Dealing with an "intermediate" breast cancer recurrence score?

1:56

Dealing with an "intermediate" breast cancer recurrence score?
Will I need Chemotherapy for My Breast Cancer?

14:48

Will I need Chemotherapy for My Breast Cancer?
Artsen vertellen over de MammaPrint - Thijs van Dalen

1:03

Artsen vertellen over de MammaPrint - Thijs van Dalen
Short Documentary

5:29

Short Documentary
Genomic assay performance: core needle biopsy vs. surgical resection samples

2:19

Genomic assay performance: core needle biopsy vs. surgical resection samples
Beating Breast Cancer Without Chemo, Radiation or Tamoxifen

21:56

Beating Breast Cancer Without Chemo, Radiation or Tamoxifen
Adam Brufsky, MD - University of Pittsburgh Medical Center

2:32

Adam Brufsky, MD - University of Pittsburgh Medical Center
Mammaprint en la toma de decisiones clínicas en Ca de mama temprano actualización 2021

21:05

Mammaprint en la toma de decisiones clínicas en Ca de mama temprano actualización 2021
Aleseia's Story

3:11

Aleseia's Story
The management of breast cancer in the Japanese population

4:01

The management of breast cancer in the Japanese population
Cutting Edge Advances in Breast Cancer Treatment:

1:52

Cutting Edge Advances in Breast Cancer Treatment:
Jennifer Tittensor, MD FACS Presents Case Study On Low Risk, 76 Yr Patient, Large Tumor-mammogram

1:21

Jennifer Tittensor, MD FACS Presents Case Study On Low Risk, 76 Yr Patient, Large Tumor-mammogram
Poster comparing Oncotype dx and Mammaprint

4:29

Poster comparing Oncotype dx and Mammaprint
MammaPrint Study Spares Breast Cancer Patients Chemo

2:30

MammaPrint Study Spares Breast Cancer Patients Chemo
Genomic Profiling of Breast Cancer in African-American Women

3:09

Genomic Profiling of Breast Cancer in African-American Women
MINDACT: adjuvant chemotherapy in breast cancer

8:10

MINDACT: adjuvant chemotherapy in breast cancer
CÂNCER DE MAMA | Como definir quem precisa de quimioterapia? Exames de Oncotype e Mammaprint

4:45

CÂNCER DE MAMA | Como definir quem precisa de quimioterapia? Exames de Oncotype e Mammaprint
CÂNCER DE MAMA | Como saber se é necessário quimioterapia depois da cirurgia? Mammaprint e Oncotype

6:32

CÂNCER DE MAMA | Como saber se é necessário quimioterapia depois da cirurgia? Mammaprint e Oncotype
Individuelles Risiko – Therapie nach Maß; MammaPrint + BluePrint – Mehr wissen, besser entscheiden!“

1:08:16

Individuelles Risiko – Therapie nach Maß; MammaPrint + BluePrint – Mehr wissen, besser entscheiden!“
Beneficios del uso de Mammaprint+Blueprint en cáncer de mama

2:54

Beneficios del uso de Mammaprint+Blueprint en cáncer de mama
MammaPrint®, el análisis genómico del riesgo de recaída para cáncer de mama

1:38

MammaPrint®, el análisis genómico del riesgo de recaída para cáncer de mama
Jennifer Tittensor, MD FACS Presents Case Study On Why MammaPrint And BluePrint Is So Important

1:17

Jennifer Tittensor, MD FACS Presents Case Study On Why MammaPrint And BluePrint Is So Important
ONN Preview: Priority Review in Ovarian Cancer, Mixed Results in Myelofibrosis, and More

00:31

ONN Preview: Priority Review in Ovarian Cancer, Mixed Results in Myelofibrosis, and More
Neoadjuvant Endocrine Therapy in Breast Cancer

57:06

Neoadjuvant Endocrine Therapy in Breast Cancer
Experts Comment, Agendia Breast Cancer Assays - Phillip Ley, MD

00:59

Experts Comment, Agendia Breast Cancer Assays - Phillip Ley, MD
The Latest: What To Do If You Have An Intermediate Oncotype Recurrence Score

13:39

The Latest: What To Do If You Have An Intermediate Oncotype Recurrence Score
Molecular Subtyping with Breast Cancer

2:11

Molecular Subtyping with Breast Cancer
[ Ep.12 ] 유방암 항암치료 여부를 결정하는 맘마프린트 검사

10:55

[ Ep.12 ] 유방암 항암치료 여부를 결정하는 맘마프린트 검사
Priority Review in Ovarian Cancer, Rolling Submission in ALK-Positive NSCLC, and More

5:27

Priority Review in Ovarian Cancer, Rolling Submission in ALK-Positive NSCLC, and More
Jennifer Tittensor, MD FACS Presents The Benefits Of BluePrint, Molecular Subtype Assay

1:05

Jennifer Tittensor, MD FACS Presents The Benefits Of BluePrint, Molecular Subtype Assay